Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A vaccine vial on a laboratory countertop in a dimly lit lab setting.

Oct 27, 2026

NEC joins EU AI vaccine project for pandemic readiness

NEC has joined the EU-funded PREPAIR VAC initiative, focusing on enhancing pandemic preparedness through AI-driven vaccine design.The PREPAIR VAC project, backed by Horizon Europe, aims to streamline vaccine development in response to emerging infectious diseases. With a budget of approximately €6.5 million, the four-year initiative includes NEC OncoImmunity, which will lead efforts in antigen prediction and AI-based vaccine design. The consortium, coordinated by the European Vaccine Initiative,
A flat illustration of a DNA strand representing life sciences research.

Oct 27, 2026

Anthropic opens life sciences AI research program | ETIH EdTech News

Anthropic has launched a new initiative aimed at advancing life sciences research by allowing selected teams to collaborate with its scientists and utilize internal AI models free of charge.The recently announced guest investigator program invites researchers from universities, nonprofit organizations, and government labs to apply for an 8 to 12-week collaboration with Anthropic. This program, which opened on October 22, 2026, seeks proposals in five key areas: causal human biology, structural a
Syringe with fertility culture medium in a lab setting

Oct 26, 2026

UCSF, Conceivable Life Sciences to Launch AI-Robotics IVF Center to Cut Outcome Variability

The University of California, San Francisco (UCSF) has partnered with Conceivable Life Sciences to establish a pioneering Fertility Excellence Center aimed at enhancing in vitro fertilization (IVF) outcomes.This new center, set to be located on UCSF’s Mission Bay campus, will utilize the AURA platform, which integrates AI and robotics to standardize and measure each step of the IVF process. This approach is designed to minimize variability in outcomes, a common challenge in fertility treatments.
A minimalist representation of a clinical trial document and an AI agent.

Oct 26, 2026

Virtual biotech deploys 37,000 AI agents across drug discovery

A virtual biotech company has harnessed the power of 37,000 AI agents to revolutionize drug discovery, analyzing around 50,000 clinical trials to identify key molecular features that enhance drug development outcomes.Developed by researchers at Stanford Medicine, this innovative project operates like a traditional biotech firm, with specialized AI agents functioning in roles akin to those of human researchers. Each agent is tasked with analyzing specific clinical trials, significantly reducing t
A test tube with a biological sample in a dimly lit lab setting.

Oct 26, 2026

World HUPO 2026: Asia-Pacific Ambition and the Road to Predictive Biology

The World HUPO 2026 congress in Singapore showcased a vibrant intersection of proteomics, technology, and collaborative ambition, emphasizing predictive biology's potential.The event attracted 1,428 participants from 45 nations, under the theme “Proteomics Plus: Transforming Lives.” Discussions transcended traditional proteomics, focusing on broader questions about disease prediction and treatment efficacy. The agenda included workshops, competitions for early-career researchers, and an interact
A vial of biopharmaceutical compound on a lab countertop in a dimly lit setting.

Oct 26, 2026

How Autonomous AI Is Reshaping Biopharma Operations

The biopharmaceutical sector is undergoing a significant transformation as autonomous AI systems evolve from mere analytical tools to self-executing agents capable of managing complex workflows.The transition to this "agentic era" marks a pivotal change in how AI is utilized within the industry. Previously, AI served primarily as a resource for data analysis, helping researchers identify potential drug targets and streamline clinical trial processes. Now, however, these systems are taking on a m
A minimalist representation of a cancer cell in a tumor ecosystem.

Oct 26, 2026

Spatial Proteomics for Precision Oncology

Recent advancements in spatial proteomics, particularly through imaging mass cytometry (IMC), are transforming precision oncology by enhancing our understanding of tumor ecosystems.Dr. Bernd Bodenmiller, a leading figure in quantitative biomedicine at the University of Zürich, has been instrumental in developing innovative techniques to analyze the complex interactions within tumor environments. His research focuses on how the spatial arrangement and diversity of cancer cell phenotypes influence
A notebook and coffee cup on a conference table during a team meeting.

Oct 26, 2026

Virtual care innovation needs more than great ideas

Effective virtual care innovation hinges on collaborative efforts across multiple departments within healthcare organizations, rather than solely on technological advancements.In the latest episode of the "Future of Virtual Care" podcast, Marcelo Grabois, a member of the ISO/TC 279 Committee, emphasizes the importance of a unified approach among clinical, IT, procurement, cybersecurity, finance, legal, and executive teams. Many healthcare organizations falter by prioritizing technology over a cl
Press release cover image

Oct 26, 2026

Press release

Expert Intelligence Appoints Rajiev Grover as Chief Commercial Officer

Company strengthens commercial leadership to scale AI deployments as wet laboratories face growing demand from AI-driven drug discovery.SANTA CLARA,Calif., Oct 26, 2026 — Expert Intelligence, a provider of AI-powered analyticalworkflow automation, today announced the appointment of Rajiev Grover as ChiefCommercial Officer. Rajiev will lead revenue, commercial strategy, customergrowth and strategic partnerships, helping pharmaceutical, biotechnology andtesting organizations bring AI into everyday
Press release cover image

Oct 26, 2026

Press release

ProclaimRx Launches The Next Generation Marketing Mix Modeling (MMM) Product for Commercial-Stage Biopharma Companies

Pharma-trained AI turns your MMM into a living operating model, giving commercial teams transparent, on-demand answers on how to maximize their investments.TIBURON, Calif., Oct. 26, 2026 /PRNewswire/ -- ProclaimRx, the award-winning pharma commercial intelligence and decision workflows platform, today launched its advanced MMM product.The MMM process has traditionally been a laborious, annual exercise. While valuable, these modeling efforts can take months to build. Often by the time the analysi
Press release cover image

Oct 26, 2026

Press release

The Regulation Of New Medical Tech Is Becoming A Lifelong Process

The Regulation Of New Medical Tech Is Becoming A Lifelong ProcessFor most of the history of medical deviceregulation, approval has been treated as a single moment: a device is tested,assessed and authorised, and the questions that follow are largely aboutwhether it keeps performing as it did on the day it was approved. Artificialintelligence as a medical device (AIaMD) does not fit that model well. Softwarecan be updated, retrained or deployed in settings its developers did not fullyanticipate,
Press release cover image

Oct 26, 2026

Press release

Nature Medicine Study of 8,000+ Women Finds Significant Weight Loss and 91% Treatment Retention With Digital GLP-1 Care

Research conducted in partnership with University College London examines personalised dosing, clinical monitoring and metabolic health outcomes in women receiving GLP-1 treatmentLONDON, Oct. 26, 2026 /PRNewswire/ -- A new study published in the peer-reviewed journal Nature Medicine found that women receiving GLP-1 medication through a structured digital healthcare programme developed bySheMed experienced significant weight loss, improvements in metabolic health and high treatment retention over